ONWARD® Medical plant Webcast zur Vorstellung des Geschäftsverlaufs im 1. Quartal 2024
15 mai 2024 18h43 HE
|
ONWARD Medical NV
EINDHOVEN, Niederlande, May 16, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), das Medizintechnologieunternehmen, das innovative Rückenmarkstimulationstherapien entwickelt, um die...
ONWARD® Medical organise un webinaire pour présenter l’état des lieux de ses activités du premier trimestre 2024
15 mai 2024 18h43 HE
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, 16 mai 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société de technologie médicale à l’origine de thérapies innovantes ciblées sur la restauration du...
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
14 mai 2024 18h21 HE
|
ONWARD Medical NV
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions
02 mai 2024 21h31 HE
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, 03 mai 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société de technologie médicale à l’origine de thérapies innovantes ciblées sur la restauration du...
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
02 mai 2024 01h00 HE
|
ONWARD Medical NV
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour
26 avr. 2024 09h17 HE
|
ONWARD Medical NV
Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande « De Novo ») Levée de fonds de 20 millions d’euros Annonce des résultats...
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
25 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
11 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
09 avr. 2024 01h00 HE
|
ONWARD Medical NV
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
02 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System.